House Bill No. 312, known as the "Ivermectin Access Law," proposes to allow the over-the-counter sale and purchase of ivermectin without a prescription in Louisiana. The bill enacts a new part of the Louisiana Revised Statutes, specifically R.S. 40:1051 through 1053, which includes definitions for key terms such as "healthcare professional," "ivermectin," and "over-the-counter medication." Ivermectin is defined as an FDA-approved antiparasitic drug used to treat various tropical diseases, infections caused by parasitic worms, head lice, and skin conditions like rosacea.

The bill explicitly states that ivermectin suitable for human use may be sold or purchased as an over-the-counter medication in the state, and this transaction will not require a prescription from any healthcare professional. This legislation aims to increase access to ivermectin for consumers, reflecting a shift in how this medication can be obtained in Louisiana.